Eli Lilly and Company

Other

Jeffrey Alan Kyle

Michael Robert Wiley

John Joseph Masters

Valentine Joseph Klimkowski

Jason Scott Sawyer

Gerald Floyd Smith

Douglas Wade Beight

Steven E Hall

James Howard Wikel

Robert T Shuman

David Kent Herron

Ying Kwong Yee

David Mendel

Jennifer Marie Tinsley

Anne Louise Tebbe

Leonard Crayton Weir

Trelia Joyce Craft

Jeffry Bernard Franciskovich

Guy Milot

Theodore Goodson, Jr

Sajan Joseph

Marta Maria Pi&ntilde;eiro-N&uacute;&ntilde;ez

Carl Penman Denny

Marta Maria Pi&ntilde;eiro-Nu&ntilde;ez

Theodore Goodson, Junior

John E Munroe

Stephen W Kaldor

James E Fritz

Marta Maria Pineiro-Nunez

Marta Maria Pinelro-Núnez

Guy Milet

Theodore Goodson Jr

Jeffrey Bernard Franciskovich

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Aromatic amides

Antithrombotic amides

This application relates to heteroaromatic amides (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Heteroroaromatic amides as inhibitor of factor Xa

Heterocyclic amides as inhibitors of factor Xa

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermidates thereof.

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Antithrombotic agents

This application relates to a compound of formula (I), a pharmaceutically acceptable salt of the compound, or a prodrug thereof, as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Growing community of inventors

Fishers, IN, United States of America

Jeffrey Alan Kyle